Mucopolysaccharidosis (MPS IIIA) mice have increased lung compliance and airway resistance, decreased diaphragm strength, and no change in alveolar structure
American Journal of Physiology-Lung Cellular and Molecular Physiology · 2024
DOI: 10.1152/ajplung.00445.2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, 2024. Verfasst von Tamara L Paget und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mechanisms in Cell Biology and Diseases Research Concentration, Clinical & Health Sciences, University of South Australia, Adelaide, South Australia,…. Hauptthemen laut MEDLINE: Diaphragm, Airway Resistance, Pulmonary Alveoli, Mucopolysaccharidosis III. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Sansom Institute for Health Research, Lung Foundation Australia (LFA), University of South Australia (UniSA).
Abstract (Originalsprache)
Heparan sulfate storage in the lungs of mucopolysaccharidosis type IIIA (MPS IIIA) mice leads to changes in lung function consistent with those of an obstructive lung disease and includes an increase in lung compliance and airway resistance and a decrease in tissue elastance. In addition, diaphragm muscle contractile strength is reduced, potentially further contributing to lung function impairment. However, no changes in parenchymal lung structure were observed in mice at 20 wk of age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mechanisms in Cell Biology and Diseases Research Concentration, Clinical & Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
- Respiratory Environmental Health, Wal-yan Respiratory Research Centre, Telethon Kids Institute, Perth, Western Australia, Australia.
- Occupation, Environment & Safety, School of Population Health, Curtin University, Perth, Western Australia, Australia.
- School of Human Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
- Hannover Medical School, Institute of Functional and Applied Anatomy, Hannover, Germany.
- Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover Medical School, Hannover, Germany.
ORCID-Profile: Tamara L Paget, Alexander N Larcombe, Gavin J Pinniger, Sandra Orgeig
Förderung
- Sansom Institute for Health Research
- Lung Foundation Australia (LFA)
- University of South Australia (UniSA)
- Commonwealth Government of Australia
- Hannover Medical School via the funding program "Junge Akademie 2.0"
- Hannover Medical School via the funding program
Zitieren
APA
Paget, T. L., Larcombe, A. N., Pinniger, G. J., Tsioutsias, I., Schneider, J. P., Parkinson-Lawrence, E. J., & Orgeig, S. (2024). Mucopolysaccharidosis (MPS IIIA) mice have increased lung compliance and airway resistance, decreased diaphragm strength, and no change in alveolar structure. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00445.2022
Vancouver
Paget TL, Larcombe AN, Pinniger GJ, Tsioutsias I, Schneider JP, Parkinson-Lawrence EJ, et al. Mucopolysaccharidosis (MPS IIIA) mice have increased lung compliance and airway resistance, decreased diaphragm strength, and no change in alveolar structure. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2024. doi:10.1152/ajplung.00445.2022
BibTeX
@article{Paget2024,
author = {Paget, Tamara L and Larcombe, Alexander N and Pinniger, Gavin J and Tsioutsias, Irene and Schneider, Jan Philipp and Parkinson-Lawrence, Emma J and Orgeig, Sandra},
title = {Mucopolysaccharidosis (MPS IIIA) mice have increased lung compliance and airway resistance, decreased diaphragm strength, and no change in alveolar structure},
journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
year = {2024},
doi = {10.1152/ajplung.00445.2022}
}
EUVIMED